ATF4 and melanoma: Although we observed a high recovery of ATF4 after co-treatment of melanoma cells with ACF and MG132 (Figure 4D), suggesting ATF4 protein stability was reduced by ACF, MG132, per se, is an activator of the unfolded protein response (UPR), making interpretation of this experiment difficult.